• Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
    • Schrijver LH, Antoniou AC, Olsson H, Mooij TM, Roos-Blom MJ, Azarang L, Adlard J, Ahmed M, Barrowdale D, Davidson R, Donaldson A, Eeles R, Evans DG, Frost D, Henderson A, Izatt L, Ong K, Bonadona V, Coupier I, Faivre, L, Fricker JP, Gesta P, Van Engelen K, Jager A, Menko FH, Mourits MJE, Singer CF, Tan YY, Foretova L, Navratilova M, Schmutzler RK, Ellberg C, Gerdes AM, Caldes T, Simard J, Olah E, Jakubowska A, Rantala J, Osorio A, Hopper JL, Phillips KA, Milne RL, Terry MB, Nogues C, Engel C, Kast K, Goldgar DE, van Leeuwen FE, Easton DF, Andrieu N, Rookus MA, on behalf ofEMBRACE, GENEPSO, HEBON and IBCCS.
    • Am J Obstet Gynecol. 2021 Jan 21. pii: S0002-9378(21)00038-7. doi: 10.1016/j.ajog.2021.01.014. Epub ahead of print.